Recombinant yeast transformant and process for preparing immunoglobulin fc fragment employing the same
US-2015361437-A1 · Dec 17, 2015 · US
Compositions and methods for 3-hydroxypropionic acid production
US9777280B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9777280-B2 |
| Application number | US-201615060036-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 3, 2016 |
| Priority date | Nov 22, 2010 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present application discloses genetically modified yeast cells comprising an active 3-HP fermentation pathway, and the use of these cells to produce 3-HP.
First claim
Opening claim text (preview).
What is claimed is: 1. A genetically modified yeast cell selected from the group consisting of I. orientalis, C. lambica , and S. bulderi , the genetically modified yeast cell comprising an active 3-HP fermentation pathway, wherein the cell comprises an exogenous BAAT or gabT gene encoding an enzymatically active polypeptide with at least 85% sequence identity to an amino acid sequence selected from SEQ ID NOs: 20, 21, and 24. 2. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 90% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24. 3. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 95% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24. 4. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 97% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24. 5. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 98% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24.
Assignees
Inventors
Classifications
- C12N1/18Primary
Baker's yeast; Brewer's yeast · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Beta-alanine-pyruvate transaminase (2.6.1.18) · CPC title
4-Aminobutyrate—2-oxoglutarate transaminase (2.6.1.19) · CPC title
Aspartate transaminase (2.6.1.1), i.e. aspartate-aminotransferase · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9777280B2 cover?
- The present application discloses genetically modified yeast cells comprising an active 3-HP fermentation pathway, and the use of these cells to produce 3-HP.
- Who is the assignee on this patent?
- Cargill Inc, Cargill Inc
- What technology area does this patent fall under?
- Primary CPC classification C12N1/18. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).